Biden Administration Will Ship COVID-19 Vaccines Directly To Pharmacies

Enlarge this image


A pharmacy technician prepares doses of the Pfizer-BioNTech vaccine at a mass vaccination event on Saturday in Denver.





Michael Ciaglo/Getty Images



hide caption



toggle caption


Michael Ciaglo/Getty Images



Shots — Health News
COVID-19 Vaccine: Will It Protect Against New Variants And Do You Need A 2nd Dose?

The program will begin on Feb. 11 on a limited basis, with vaccines sent to about 6,500 stores nationwide, Jeff Zients, the White House’s COVID-19 response coordinator, told reporters on Tuesday. He said the effort would then scale up, and that eventually up to 40,000 retail pharmacies, including Walgreens, CVS and Rite Aid locations, would receive doses directly from the federal government.

Once the program starts, Zients said those wishing to get vaccinated should follow their state’s current eligibility requirements and, if eligible, then check with their local pharmacy to see if there is vaccine availability.



Coronavirus Updates
Early Data Shows Striking Racial Disparities In Who’s Getting The COVID-19 Vaccine

In his remarks, Zients stressed that equity of vaccine distribution is a key component of the pharmacy effort. In many locations around the U.S., white people are getting vaccinated at much higher rates than are people of color.

«[Pharmacy] sites are selected based on their ability to reach some of the populations most at risk for severe illness from COVID-19, including socially vulnerable communities, said Zients, who added that the Centers for Disease Control and Prevention will monitor the site data for equity concerns.

The pharmacy program was first reported by Politico.

Zients, who had just completed a call with governors, also announced a slight increase in the doses states could expect over the next few weeks, from 10 million doses a week to about 10.5 million. The Biden administration had just announced that short-term increase up to 10 million doses a week, from 8.6 million.



Shots — Health News
Moderna Increases COVID-19 Vaccine Shipments While Pfizer Lags Behind



President Biden Takes Office
The Biden Administration Is Working To Buy 200 Million More COVID-19 Vaccine Doses

NPR reported Monday that vaccine-maker Moderna had made significant progress in increasing its shipments to the U.S. government, while Pfizer, which has an authorized vaccine with its German counterpart BioNTech, was lagging behind.

Zients also said that the Federal Emergency Management Agency would fully reimburse states for National Guard activations and other emergency provisions related to COVID-19, going back to the beginning of the pandemic, in January 2020. That funding does not require congressional action and will come at a cost of $3 billion to $5 billion, Zients estimated.

President Biden has pledged getting 100 million vaccine doses into arms in the first 100 days of his administration. That pace, of 1 million doses a day, is already being surpassed. White House officials have called Biden’s goal «a floor not a ceiling.